Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease

The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in t...

Full description

Saved in:

Bibliographic Details
Published in:	Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny Vol. 7; no. 3; pp. 13 - 19
Main Authors:	V. V. Novitsky, R. S. Karpov, M. Yu. Kotlovsky, S. V. Klemenkov, O. V. Voronkova, V. A. Shulman, S. Yu. Nikulina, S. V. Mashkovskaya, D. A. Kirichenko, Ye. N. Ivtchenko, A. A. Masterova, K. V. Zlodeyev, Yu. V. Kotlovsky
Format:	Journal Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 30-09-2008
Subjects:	жирные кислоты ишемическая болезнь сердца симвастатин
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The intake of Simvastatin in a dosage of 40 mg daily within two months in patients with ischemia heart disease has caused increase in the general percentage of ω6 fat acids (FA) at a constant level of ω3 FA, that was not accompanied by change of a ratio ω3/ω6 FA. Despite of progressing increase in total concentration of ω7 FA (at women) and increase of a level ω9 FA (at men) during simvastatin treatment at women and at men led to decrease in the total percentage of nonsaturated fat acids concerning corresponding parameters at healthy donors. The Simvastatin treatment was accompanied by increase in blood plasma in patients with ischemia heart disease (and first of all at women) percentage of the separate saturated fat acids, and also their total level. The index of nonsaturation of fat acids of blood plasma is decreased.
ISSN:	1682-0363 1819-3684
DOI:	10.20538/1682-0363-2008-3-13-19